$NTRR U.S. Cannabis Industry Poised for Dramatic Expansion in 2016

The U.S. cannabis industry is still celebrating its biggest and best year ever in 2015, but natural wellness solutions company Neutra Corp. (NTRR) is already working on innovative products to capitalize on even more dramatic growth to come in 2016. Some analysts are predicting that the U.S. cannabis industry could grow by another six states in the next 12 months.

The staff of Fortune magazine recently forecast that cannabis ballot initiatives could open the door to legalization in Arizona, California, Maine, Massachusetts, Michigan and Nevada in the coming year, with other states potentially jumping aboard the bandwagon, as well. With the 2016 Presidential election likely to increase voter turnout among younger, more cannabis-friendly voters, in particular, NTRR and others marketing products ancillary to the booming industry are setting ambitious goals for the year to come.

“2015 was the most important year yet for the emerging U.S. cannabis industry, with Washington and Colorado raking in millions in tax dollars,” said NTRR CEO Chris Brown. “According to a recent Gallup poll reported by Fortune, nationwide support for cannabis stands at 58 percent. With every successful industry rollout, more and more states are going to seriously consider cannabis initiatives, and we expect several to pass in 2016.”

The company won’t limit its efforts to the United States, however. In the coming year, NTRR plans to unveil many new products to capitalize on the historic growth of the cannabis industry in the U.S., Canada and elsewhere. Last week, NTRR signed a letter of intent to partner with a Canadian company to help market and develop new cannabis-infused topical formulas.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPH), Cara Therapeutics Inc. (CARA) and 22nd Century Group, Inc. (XXII), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

View source version on businesswire.com:https://www.businesswire.com/news/home/20151215005713/en/